N27 - Autonomic pharmacology 2 Flashcards
Give an overview of neurochemical transmission in the ANS.
1.Uptake of precursor
2. Synthesis of transmitter (T) or intermediate
3. Storage of transmitter (T) or intermediate
4. Depolarization by action potential
5. Ca2+ entry via voltage -activated Ca2+ channels
6. Ca2+ induced release of transmitter (exocytosis)
7. Receptor activation
8.Enzyme-mediated inactivation of transmitter (cholinergic)
OR
9. Reupatke of transmitter (adrenergic)
what are all these steps a target for?
drug target (often clinical significance)
What are the general features of cholinergic transmission.
- Uptake of choline via transporter (CHT). Rate limiting in synthesis of ACh
- Synthesis of ACh by choline acetyltransferase (ChAT). Acetyl coenzyme A (AcCoA) synthesised by mitochondria
- Storage of ACh within vesicle via transporter (VAChT). ATP and other anions are co-stored
- Depolarization of terminal by action potential
- Ca2+ influx through voltage-activated Ca2+ channels
- Ca2+- induced release of ACh from vesicles (exocytosis)
- Activation of ACh receptors (nicotinic, or muscarinic) causing cellular response
- Degradation of ACh to choline and acetate by acetylcholinesterase (AChE) – terminates transmission
- Reuptake and reuse of choline
what does the nicotinic acetylcholine (ACh) receptors consist of?
five glycoprotein subunits that form a central, cation conducting (Na+, K+ and Ca2+), channel
what is nicotinic acetylcholine receptors assembled from?
diverse range of subunits
what do nicotinic acetylcholine exist as?
numerous subtypes (dozens) that are structurally, functionally and pharmacologically distinct (4 well characterised subtypes)
what are the 4 subtypes?
peripheral: -skeletal muscle (alpha12bye) -Ganglionic (alpha3b4) CNS: -alpha4b2 -alpha 7
what is the primary event?
cholinergic transmission at ganglia
what were drugs that block the autonomic ganglia once used for?
to control hypertension
what are the effects of autonomic ganglion blockade on tissues (site, predominant tone, effects of blockade)?
- Arterioles -Sympathetic (adrenergic)-Vasodilatation; ↑ peripheral blood flow; hypotension
- Veins- Sympathetic (adrenergic) -Vasodilatation; ↑ pooling of blood; ↓ venous return; ↓ cardiac output
- Heart -Parasympathetic (cholinergic) - Tachycardia
- Iris-Parasympathetic (cholinergic)-Mydriasis (pupil constriction)
- Ciliary muscle -Parasympathetic (cholinergic) -Cycloplegia (focussed for far vision)
- G.I. tract -Parasympathetic (cholinergic) -↓ Tone and motility; constipation; ↓ secretions
- Urinary bladder -Parasympathetic (cholinergic) - Urinary retention
- Salivary glands -Parasympathetic (cholinergic) -Xerostomia (dry mouth)
- Sweat glands-Sympathetic (cholinergic)-Anhidrosis (absence of sweating)
what can blockade be achieved by?
- depolarization block by high concentrations of agonists (e.g. nicotine)
- competitive antagonism (e.g. trimetaphan)
- Non-competitive antagonism
what is all ganglionic transmission (sympathetic and parasympathetic) selectively blocked by?
hexamethonium which illustrates an interesting molecular mechanism – open channel block – a form of non-competitive antagonism
Describe the stages of cholinergic transmission at parasympathetic neuroeffector junction?
Synthesis and storage of Each as previously described
- Depolarization by action potential
- Ca2+ influx through voltage-activated Ca2+ channels
- Ca2+- induced release of ACh (exocytosis)
- Activation of muscarinic ACh receptors subtypes (M1-M3) causing cellular response (tissue dependent)
- Degradation of ACh to choline and acetate by acetylcholinesterase (AChE) – terminates transmission
- Reuptake and reuse of choline
what is cholinergic transmission at parasympathetic neuroeffector junctions between?
varicosity of post ganglion neurone and effector cell. (e.g smooth muscle cell, gland cell)
what does M1 and Gq result in (G-Protein Coupled Muscarinic ACh Receptor Subtypes at Parasympathetic Neuroeffector Junctions)?
- stimulation of phospholipase C
- increased acid secretion